Article summary
Trump Administration Vetoed Compass Pathways Priority Voucher • Ibogaine in Focus (State Bills Progress, Safety and Regulation, State Programs and Global Supply, Drug Development Remains Early-Stage, DemeRx Shares Phase 1 Data • Definium Therapeutics Sued by Former Vendor Over Alleged Trade Secret Theft • Psychedelics Surface in Newly Released Epstein Documents • Fresh State Bills Add to Growing Psychedelics Docket • and more…
Continue to the original publication for the complete article.